Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T1 mapping

Investigative Radiology

Volumn 46, Issue 10, 2011, Pages 624-631

  Braren, Rickmer ^a   Curcic, Jelena ^b   Remmele, Stefanie ^c   Altomonte, Jennifer ^a   Ebert, Oliver ^a   Rummeny, Ernst J ^a   Steingoetter, Andreas ^d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b ETH ZURICH   (Switzerland)

^c PHILIPS RESEARCH LABORATORIES   (Germany)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Dynamic T1 mapping; Golden angle view order; Hepatocellular carcinoma; Quantitative DCE MRI; Rat liver

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DYNAMIC CONTRAST ENHANCED NUCLEAR MAGNETIC RESONANCE IMAGING; GOLDEN ANGLE VIEW ORDER METHOD; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM; PRIORITY JOURNAL; RAT; SPECTROSCOPY; THREE DIMENSIONAL IMAGING;

EID: 80052504445     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e31821e30e7     Document Type: Article

References (45)

1. Barrett T, Brechbiel M, Bernardo M, et al. MRI of tumor angiogenesis. J Magn Reson Imaging. 2007;26:235-249. (Pubitemid 47257720)
2. Cheng HL. Dynamic contrast-enhanced MRI in oncology drug development. Curr Clin Pharmacol. 2007;2:111-122.
3. Marcus CD, Ladam-Marcus V, Cucu C, et al. Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives. Crit Rev Oncol Hematol. 2009;72:217-238.
4. Brix G, Lucht R, Griebel J. Tracer kinetic analysis of signal time series from dynamic contrast-enhanced MR imaging. Biomed Tech (Berl). 2006;51:325-330. (Pubitemid 46630710)
5. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10:223-232. (Pubitemid 29463104)
6. Barrett T, Kobayashi H, Brechbiel M, et al. Macromolecular MRI contrast agents for imaging tumor angiogenesis. Eur J Radiol. 2006;60:353-366.
7. Brix G, Kiessling F, Lucht R, et al. Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series. Magn Reson Med. 2004;52:420-429. (Pubitemid 39025290)
8. Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2003;17:509-520. (Pubitemid 36528666)
9. Cron GO, Kelcz F, Santyr GE. Improvement in breast lesion characterization with dynamic contrast-enhanced MRI using pharmacokinetic modeling and bookend T(1) measurements. Magn Reson Med. 2004;51:1066-1070.
10. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging. 1999;10:254-259. (Pubitemid 29463107)
11. Kuribayashi H, Bradley DP, Checkley DR, et al. Averaging keyhole pulse sequence with presaturation pulses and EXORCYCLE phase cycling for dynamic contrast-enhanced MRI. Magn Reson Med Sci. 2004;3:207-210.
12. Li X, Rooney WD, Springer CS Jr. A unified magnetic resonance imaging pharmacokinetic theory: intravascular and extracellular contrast reagents. Magn Reson Med. 2005;54:1351-1359. (Pubitemid 41740764)
13. Murase K, Yamazaki Y, Miyazaki S. Deconvolution analysis of dynamic contrast-enhanced data based on singular value decomposition optimized by generalized cross validation. Magn Reson Med Sci. 2004;3:165-175.
14. Roberts C, Buckley DL, Parker GJ. Comparison of errors associated with single-and multi-bolus injection protocols in low-temporal-resolution dynamic contrast-enhanced tracer kinetic analysis. Magn Reson Med. 2006;56: 611-619. (Pubitemid 44338880)
15. Srikanchana R, Thomasson D, Choyke P, et al. A comparison of pharmacokinetic models of dynamic contrast enhanced MRI. In: Proceedings of 17th IEEE Symposium on Computer-Based Medical Systems; 2004; (Bethesda): MD.
16. Yankeelov TE, Luci JJ, Lepage M, et al. Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. Magn Reson Imaging. 2005;23:519-529. (Pubitemid 40779238)
17. Zhou R, Pickup S, Yankeelov TE, et al. Simultaneous measurement of arterial input function and tumor pharmacokinetics in mice by dynamic contrast enhanced imaging: effects of transcytolemmal water exchange. Magn Reson Med. 2004;52:248-257. (Pubitemid 39025268)
18. Heilmann M, Kiessling F, Enderlin M, et al. Determination of pharmacokinetic parameters in DCE MRI: consequence of nonlinearity between contrast agent concentration and signal intensity. Invest Radiol. 2006;41:536-543. (Pubitemid 44284189)
19. Li KL, Zhu XP, Waterton J, et al. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging. 2000;12:347-357. (Pubitemid 30612881)
20. Zech CJ, Vos B, Nordell A, et al. Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA. Invest Radiol. 2009;44:305-310.
21. Cheng HL, Wright GA. Rapid high-resolution T(1) mapping by variable flip angles: accurate and precise measurements in the presence of radiofrequency field inhomogeneity. Magn Reson Med. 2006;55:566-574. (Pubitemid 43352555)
22. Frulio N, Trillaud H, Deckers R, et al. Influence of ultrasound induced cavitation on magnetic resonance imaging contrast in the rat liver in the presence of macromolecular contrast agent. Invest Radiol. 2010;45:282-287.
23. Look DC, Locker DR. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum. 1970;41:250-251.
24. Katsube T, Okada M, Kumano S, et al. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol. 2011;46:277-283.
25. Winkelmann S, Schaeffter T, Koehler T, et al. An optimal radial profile order based on the Golden Ratio for time-resolved MRI. IEEE Trans Med Imaging. 2007;26:68-76. (Pubitemid 46096351)
26. Deichmann R, Haase A. Quantification of T1 Values by snapshot-FLASH NMR Imaging. J Magn Reson. 1992;96:608-612.
27. Deoni SC, Rutt BK, Peters TM. Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state. Magn Reson Med. 2003;49: 515-526. (Pubitemid 36262820)
28. Landis CS, Li X, Telang FW, et al. Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange. Magn Reson Med. 2000;44:563-574.
29. Landis CS, Li X, Telang FW, et al. Equilibrium transcytolemmal waterexchange kinetics in skeletal muscle in vivo. Magn Reson Med. 1999;42: 467-478. (Pubitemid 29416208)
30. Rohrer M, Bauer H, Mintorovitch J, et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40:715-724. (Pubitemid 41546838)
31. Steingoetter A, Svensson J, Kosanke Y, et al. Reference region-based pharmacokinetic modeling in quantitative dynamic contract-enhanced MRI allows robust treatment monitoring in a rat liver tumor model despite cardiovascular changes. Magn Reson Med. 2011;65:229-238.
32. Donahue KM, Weisskoff RM, Parmelee DJ, et al. Dynamic Gd-DTPA enhanced MRI measurement of tissue cell volume fraction. Magn Reson Med. 1995;34:423-432.
33. McGrath DM, Bradley DP, Tessier JL, et al. Comparison of model-based arterial input functions for dynamic contrast-enhanced MRI in tumor bearing rats. Magn Reson Med. 2009;61:1173-1184.
34. Yankeelov TE, Cron GO, Addison CL, et al. Comparison of a reference region model with direct measurement of an AIF in the analysis of DCE-MRI data. Magn Reson Med. 2007;57:353-361. (Pubitemid 46214538)
35. Haacke EM, Brown RW, Thompson MR, et al. Magnetic Resonance Imaging: Physical Principles and Sequence Design. New York, NY: John Wiley & Sons, Inc.; 1999.
36. Yankeelov TE, Rooney WD, Li X, et al. Variation of the relaxographic "shutter-speed" for transcytolemmal water exchange affects the CR bolustracking curve shape. Magn Reson Med. 2003;50:1151-1169. (Pubitemid 37494016)
37. Orton MR, Miyazaki K, Koh DM, et al. Optimizing functional parameter accuracy for breath-hold DCE-MRI of liver tumours. Phys Med Biol. 2009; 54:2197-2215.
38. Ashton E, Raunig D, Ng C, et al. Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions. J Magn Reson Imaging. 2008;28:791-796.
39. Chalmers CR, Wilson DJ, Ward J, et al. Antiangiogenic activity of the selective cyclooxygenase 2 inhibitor rofecoxib in human colorectal cancer liver metastases. Gut. 2006;55:1058-1059. (Pubitemid 43962636)
40. Kershaw LE, Buckley DL. Precision in measurements of perfusion and microvascular permeability with T1-weighted dynamic contrast-enhanced MRI. Magn Reson Med. 2006;56:986-992. (Pubitemid 44691340)
41. Lin W, Guo J, Rosen MA, et al. Respiratory motion-compensated radial dynamic contrast-enhanced (DCE)-MRI of chest and abdominal lesions. Magn Reson Med. 2008;60:1135-1146.
42. Parker GJ, Roberts C, Macdonald A, et al. Experimentally derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med. 2006;56:993-1000. (Pubitemid 44691341)
43. Yang X, Liang J, Heverhagen JT, et al. Improving the pharmacokinetic parameter measurement in dynamic contrast-enhanced MRI by use of the arterial input function: theory and clinical application. Magn Reson Med. 2008;59:1448-1456. (Pubitemid 351813276)
44. Fram EK, Herfkens RJ, Johnson GA, et al. Rapid calculation of T1 using variable flip angle gradient refocused imaging. Magn Reson Imaging. 1987; 5:201-208. (Pubitemid 17133355)
45. Cheng HL. T1 measurement of flowing blood and arterial input function determination for quantitative 3D T1-weighted DCE-MRI. J Magn Reson Imaging. 2007;25:1073-1078.